Tag: Competition

Displaying 1 - 20 of 1163 results.

Pages

Filtering by content type: Press Release

Federal Trade Commission Acting Chairman Maureen K. Ohlhausen released a summary of the agency’s major accomplishments since President Trump named her to the position in January. “I have pursued my long-held principles by promoting economic liberty, protecting consumers (including the military...
Baxter International Inc. and Claris Lifesciences Limited have agreed to divest two types of pharmaceutical products to settle Federal Trade Commission charges that Baxter’s proposed $625 million acquisition of Claris’ injectable drugs business is anticompetitive.According to a complaint filed by...
Federal Trade Commission Acting Chairman Maureen K. Ohlhausen announced today that she has selected D. Bruce Hoffman, a partner at the law firm of Shearman & Sterling LLP, to be the Acting Director of the FTC’s Bureau of Competition, effective August 7, 2017.
Federal Trade Commission staff submitted an additional public comment to the Tennessee Department of Health that opposes issuing a certificate of public advantage (COPA) to Mountain States Health Alliance and Wellmont Health System that would allow the two companies to merge.
Acting Federal Trade Commission Chairman Maureen K. Ohlhausen has appointed Neil Alan Chilson as the agency’s acting Chief Technologist.Chilson will be primarily responsible for advising Chairman Ohlhausen and the Commission on technology matters, including the FTC’s use of technology, technical...
Acting Federal Trade Commission Chairman Maureen K. Ohlhausen announced that FTC Bureau of Economics Director Ginger Zhe Jin is departing the agency to return to the University of Maryland and has named Michael G. Vita Acting Director of the Bureau.“Ginger was an outstanding Bureau Director,...
The Federal Trade Commission has approved a sublicense submitted by Mallinckrodt ARD Inc. granting West Therapeutic Development, LLC certain rights to develop and market the specialty drug Synacthen Depot in the United States.Synacthen Depot contains a synthetic version of adrenocorticotropic...
Following a public comment period, the Federal Trade Commission has approved an application from LaFargeHolcim, Ltd to amend several agreements that were part of a 2015 FTC order settling charges that the $25 billion merger of Holcim Ltd. and Lafarge S.A. would likely harm competition in the United...
“The parties’ decision to abandon this transaction is a clear win for American consumers,” said Markus H. Meier, Acting Director of the Bureau of Competition. “For years, the vigorous competition between DraftKings and FanDuel has spurred innovation and favorable pricing. In brief, consumers...
The FTC’s Economic Liberty Task Force has announced the agenda for its first Roundtable, Streamlining Licensing Across State Lines
The Federal Trade Commission has approved the appointment of Quantic Regulatory Services, LLC as monitor in its case alleging that Endo Pharmaceuticals Inc. violated antitrust laws by using pay-for-delay settlements to block consumers’ access to lower-cost generic versions of Opana ER and Lidoderm.
In response to a request from North Carolina Assistant Attorney General Roberta A. Ouellette, the directors of the Federal Trade Commission’s Office of Policy Planning, Bureau of Competition and Bureau of Economics have issued a comment on the competitive impact of proposed legislation affecting...
Federal Trade Commission Acting Chairman Maureen K. Ohlhausen announced today that Abbott (Tad) Lipsky, Acting Director of the FTC’s Bureau of Competition, retired effective July 3, 2017. Lipsky was previously a partner in the law firm of Latham & Watkins LLP, and brought 40 years of experience...
Semiconductor manufacturer Broadcom Limited has agreed to establish a firewall to remedy the FTC’s concerns that its proposed $5.9 billion acquisition of Brocade Communications Systems, Inc. is anticompetitive. These concerns arise because of Broadcom’s current access to the confidential business...
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Emerson Electric Co.’s acquisition of Pentair plc would be anticompetitive.
The Federal Trade Commission, with the concurrence of the Antitrust Division of the U.S. Department of Justice, has approved changes to the form that companies use to report a proposed merger, acquisition, or similar transaction under the Hart-Scott-Rodino Antitrust Improvements Act.The Antitrust...
The Acting Director of the Federal Trade Commission’s Bureau of Competition, Tad Lipsky, issued the following statement on this morning’s announcement regarding Walgreens Boots Alliance, Inc.’s proposed acquisition of Rite Aid Corporation.
The Federal Trade Commission is currently accepting public comments on an application by Grifols, S.A., a manufacturer of plasma-derived drugs, to amend the terms of a manufacturing agreement that was part of a 2011 FTC-ordered divestiture.
Retail fuel station and convenience store operator Alimentation Couche-Tard Inc. has agreed to divest up to 71 retail fuel stations with convenience stores to Empire Petroleum Partners in order to settle Federal Trade Commission charges that ACT’s proposed $4.4 billion acquisition of competitor CST...
The Federal Trade Commission has authorized a federal court action to block Sanford Health’s proposed acquisition of Mid Dakota Clinic, alleging that the deal would violate antitrust law by significantly reducing competition for adult primary care physician services, pediatric services, obstetrics...

Pages